Turkish Version of the Headache Screening Questionnaire

Validity and Reliability of the Turkish Version of the Headache Screening Questionnaire

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07048132

Enrollment

200

Registered

2025-07-02

Start date

2025-07-15

Completion date

2025-12-15

Last updated

2025-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Headache, Migraine, Tension Type Headache

Keywords

migraine, tension type headache, headache, headache screening questionare, validation, reliability

Brief summary

This multi-center, nationwide study aims to evaluate the validity and reliability of the Turkish version of the Headache Screening Questionnaire (HSQ-TR). The 10-item questionnaire is designed to screen for migraine and tension-type headache in individuals with headache complaints. Participants presenting with headache will be enrolled. Each participant will first complete the HSQ-TR and then be examined by a neurologist who will provide a diagnosis according to the ICHD-3 beta criteria. The questionnaire results will be compared with the neurologist's diagnoses to assess criterion validity, including sensitivity, specificity, and agreement.

Interventions

DIAGNOSTIC_TESTHeadache Screening Questionare

The Headache Screening Questionnaire (HSQ) is a 10-item tool developed to screen for migraine and tension-type headache (TTH), based on the ICHD-3 beta criteria. Each item reflects a diagnostic criterion for migraine or TTH. Participants complete the HSQ and are also evaluated by a neurologist for diagnosis. A score of 6 or higher suggests probable migraine or probable TTH.

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Individuals aged 18 and over who present with headache complaints (migraine or tension-type) and voluntarily agree to participate

Exclusion criteria

* Individuals with severe psychiatric disorders, illiteracy in Turkish, or significant cognitive impairment preventing comprehension of the scale

Design outcomes

Primary

Measure	Time frame
ICHD-3 Beta Classification	Day 1, Two weeks later control
Headache Screening Questionare	Day 1,Two weeks later control

Contacts

Primary ContactGizem Gürsoy, Medical Doctor

drgizemgursoy@gmail.com02166321818

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026